Upgrades:
Occidental Petroleum (NYSE:OXY) was upgraded by equities
researchers at Scotiabank from a “sector perform” rating to an “outperform”
rating in a report released on Monday, The Fly reports. A number of other
research firms also recently commented on OXY. ValuEngine raised Occidental
Petroleum from a “hold” rating to a “buy” rating in a report on Wednesday, May
2nd. JPMorgan Chase raised their price target on Occidental Petroleum from
$74.00 to $75.00 and gave the stock a “neutral” rating in a report on Thursday,
February 15th. UBS began coverage on Occidental Petroleum in a report on
Wednesday, March 7th. They issued a “neutral” rating and a $71.00 price target
on the stock. Zacks Investment Research downgraded Occidental Petroleum from a
“strong-buy” rating to a “hold” rating in a report on Tuesday, March 13th.
Finally, BMO Capital Markets reissued a “hold” rating and issued a $75.00 price
target on shares of Occidental Petroleum in a report on Tuesday, February 27th.
Two analysts have rated the stock with a sell rating, ten have assigned a hold
rating and nine have issued a buy rating to the company’s stock. Occidental
Petroleum currently has a consensus rating of “Hold” and a consensus target
price of $76.94. Read more …
Welltower (NYSE:WELL) was upgraded by stock analysts at
Raymond James from a “market perform” rating to an “outperform” rating in a
research note issued to investors on Monday, MarketBeat reports. The brokerage
presently has a $60.00 price target on the real estate investment trust’s
stock. Raymond James’ price objective points to a potential upside of 7.76%
from the company’s current price. Several other equities analysts have also
recently issued reports on the stock. BMO Capital Markets upgraded shares of
Welltower from an “underperform” rating to a “market perform” rating and set a
$55.00 price target on the stock in a research report on Friday, May 18th. Zacks
Investment Research upgraded shares of Welltower from a “sell” rating to a
“hold” rating in a report on Friday, May 4th. ValuEngine cut shares of
Welltower from a “hold” rating to a “sell” rating in a report on Wednesday, May
2nd. Hilliard Lyons upgraded shares of Welltower from an “underperform” rating
to a “neutral” rating in a report on Friday, April 27th. Finally, JPMorgan
Chase restated a “neutral” rating and issued a $67.00 price objective (down
previously from $71.00) on shares of Welltower in a report on Friday, March
16th. Two research analysts have rated the stock with a sell rating, twelve
have given a hold rating and four have given a buy rating to the stock. The
stock currently has a consensus rating of “Hold” and a consensus target price
of $62.85. Read more …
Anheuser-Busch InBev (NYSE:BUD) was upgraded by Royal Bank
of Canada from an “underperform” rating to a “sector perform” rating in a note
issued to investors on Tuesday. Several other analysts also recently commented
on the stock. ValuEngine downgraded shares of Anheuser-Busch InBev from a
“sell” rating to a “strong sell” rating in a report on Tuesday. Susquehanna
Bancshares set a $127.00 price objective on shares of Anheuser-Busch InBev and
gave the company a “buy” rating in a report on Friday. Zacks Investment
Research downgraded shares of Anheuser-Busch InBev from a “hold” rating to a
“strong sell” rating in a report on Tuesday, May 15th. Sanford C. Bernstein set
a $122.00 price objective on shares of Anheuser-Busch InBev and gave the
company a “buy” rating in a report on Thursday, May 10th. Finally, Bank of
America downgraded shares of Anheuser-Busch InBev from a “neutral” rating to an
“underperform” rating and set a $115.00 price objective on the stock. in a
report on Thursday, April 26th. Five research analysts have rated the stock
with a sell rating, two have assigned a hold rating and nine have assigned a
buy rating to the stock. The stock presently has a consensus rating of “Hold”
and an average target price of $122.79. Read more …
Lowe’s (NYSE:LOW) was upgraded by equities researchers at
Loop Capital from a “hold” rating to a “buy” rating in a note issued to
investors on Wednesday. A number of other analysts also recently weighed in on
the stock. Wells Fargo & Co set a $100.00 price target on shares of Lowe’s
and gave the stock a “buy” rating in a report on Tuesday. Zacks Investment
Research raised shares of Lowe’s from a “sell” rating to a “hold” rating in a
report on Friday, May 18th. Credit Suisse Group set a $111.00 price target on
shares of Lowe’s and gave the stock a “buy” rating in a report on Monday, May 14th.
Gabelli started coverage on shares of Lowe’s in a research note on Wednesday,
April 11th. They issued a “buy” rating and a $113.00 price objective for the
company. Finally, JPMorgan Chase reissued a “neutral” rating and issued a
$100.00 price objective on shares of Lowe’s in a research note on Tuesday,
March 6th. One research analyst has rated the stock with a sell rating, nine
have issued a hold rating and twenty-five have assigned a buy rating to the
stock. Lowe’s has a consensus rating of “Buy” and a consensus target price of
$99.00. Read more …
WEC Energy Group (NYSE:WEC) was upgraded by equities
researchers at Bank of America from a “neutral” rating to a “buy” rating in a
research report issued on Wednesday, The Fly reports. Several other equities
analysts have also issued reports on the company. Zacks Investment Research
lowered WEC Energy Group from a “hold” rating to a “sell” rating in a research
note on Saturday, April 7th. Citigroup started coverage on WEC Energy Group in
a research note on Friday, April 13th. They issued a “neutral” rating and a
$61.00 price target on the stock. Wells Fargo & Co reduced their price
objective on WEC Energy Group from $73.00 to $71.00 and set a “market perform”
rating on the stock in a research report on Thursday, February 1st. Credit
Suisse Group restated a “neutral” rating and set a $63.00 price objective (down
previously from $65.00) on shares of WEC Energy Group in a research report on
Friday, February 23rd. Finally, Guggenheim restated a “buy” rating and set a
$66.00 price objective on shares of WEC Energy Group in a research report on
Friday, February 23rd. One analyst has rated the stock with a sell rating, six
have given a hold rating and four have issued a buy rating to the company. The
stock currently has an average rating of “Hold” and an average target price of
$66.00. Read more …
Canadian National Railway (NYSE:CNI) (TSE:CNR) was upgraded
by analysts at Deutsche Bank from a “sell” rating to a “hold” rating in a
research report issued to clients and investors on Thursday, The Fly reports. Other
research analysts have also issued research reports about the company. Cowen
reissued a “buy” rating and issued a $87.00 target price on shares of Canadian
National Railway in a report on Tuesday, May 15th. Bank of America raised
Canadian National Railway from an “underperform” rating to a “buy” rating and
boosted their target price for the company from $72.00 to $93.00 in a report on
Thursday, May 17th. Zacks Investment Research raised Canadian National Railway
from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 1st.
Argus lowered Canadian National Railway from a “buy” rating to a “hold” rating
in a report on Friday, February 16th. Finally, Stifel Nicolaus initiated
coverage on Canadian National Railway in a report on Thursday. They issued a
“hold” rating and a $84.00 target price on the stock. Ten investment analysts
have rated the stock with a hold rating and seven have given a buy rating to
the stock. The company has a consensus rating of “Hold” and an average target
price of $85.48. Read more …
John Deere (NYSE:DE) was upgraded by investment analysts at
UBS to a “buy” rating in a note issued to investors on Thursday, www.tipranks.com
reports. The brokerage presently has a $185.00 price objective on the
industrial products company’s stock. UBS’s price objective points to a
potential upside of 18.15% from the company’s previous close. A number of other
research analysts have also issued reports on DE. TheStreet lowered shares of
John Deere from a “b+” rating to a “c+” rating in a research note on Friday,
February 16th. Bank of America upgraded shares of John Deere from a “neutral”
rating to a “buy” rating and set a $159.00 price target on the stock in a
research note on Thursday, May 3rd. ValuEngine upgraded shares of John Deere
from a “hold” rating to a “buy” rating in a research note on Friday, February
2nd. BMO Capital Markets restated an “outperform” rating and set a $195.00
price target (up previously from $190.00) on shares of John Deere in a research
note on Wednesday, February 21st. Finally, Royal Bank of Canada restated a
“buy” rating and set a $200.00 price target on shares of John Deere in a
research note on Wednesday, April 18th. Three investment analysts have rated
the stock with a sell rating, five have given a hold rating and seventeen have
issued a buy rating to the stock. The stock has a consensus rating of “Buy” and
an average target price of $175.67. Read more …
Colgate-Palmolive (NYSE:CL) was upgraded by stock analysts
at Argus from a “hold” rating to a “buy” rating in a research report issued on
Friday, The Fly reports. The analysts noted that the move was a valuation call.
CL has been the topic of a number of other reports. Zacks Investment Research
lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in
a research report on Friday, April 6th. Morgan Stanley lowered shares of
Colgate-Palmolive from an “overweight” rating to an “equal weight” rating in a
research report on Monday, April 30th. ValuEngine lowered shares of
Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report
on Wednesday, May 2nd. Stifel Nicolaus reiterated a “hold” rating and set a
$75.00 target price on shares of Colgate-Palmolive in a research report on
Wednesday, April 18th. Finally, Citigroup reduced their target price on shares
of Colgate-Palmolive from $80.00 to $73.00 and set a “neutral” rating on the
stock in a research report on Tuesday, May 1st. Four analysts have rated the
stock with a sell rating, eleven have issued a hold rating and four have issued
a buy rating to the company’s stock. The company has an average rating of
“Hold” and an average target price of $76.38. Read more …
Novartis (NYSE:NVS) was upgraded by research analysts at
Credit Suisse Group from an “underperform” rating to a “neutral” rating in a
report released on Friday. Several other research firms have also recently
weighed in on NVS. JPMorgan Chase & Co. reissued a “neutral” rating on
shares of Novartis in a report on Thursday, May 17th. Deutsche Bank reissued a
“neutral” rating on shares of Novartis in a report on Friday, April 20th.
Finally, ValuEngine cut Novartis from a “hold” rating to a “sell” rating in a
report on Wednesday, May 2nd. Four investment analysts have rated the stock
with a sell rating, eight have given a hold rating and one has assigned a buy
rating to the company. The stock has a consensus rating of “Hold” and an
average target price of $89.81. Read more …
Downgrades:
UBS cut shares of Bristol-Myers Squibb (NYSE:BMY) from a buy
rating to a neutral rating in a research report sent to investors on Monday, www.benzinga.com
reports. UBS currently has $57.00 price target on the biopharmaceutical
company’s stock. Several other equities analysts have also recently issued
reports on the company. ValuEngine cut Bristol-Myers Squibb from a hold rating
to a sell rating in a report on Wednesday, May 2nd. Credit Suisse Group set a
$58.00 price target on Bristol-Myers Squibb and gave the company a hold rating
in a report on Thursday, April 26th. Barclays decreased their price target on
Bristol-Myers Squibb from $65.00 to $55.00 and set an equal weight rating on
the stock in a report on Friday, April 27th. BMO Capital Markets upgraded
Bristol-Myers Squibb from an underperform rating to a market perform rating in
a report on Friday, April 27th. Finally, Cowen reiterated a hold rating and
issued a $60.00 price target on shares of Bristol-Myers Squibb in a report on
Friday, April 20th. Three analysts have rated the stock with a sell rating,
thirteen have issued a hold rating and seven have assigned a buy rating to the
company. The stock currently has a consensus rating of Hold and an average
price target of $62.84. Read more …
HCP (NYSE:HCP) was downgraded by research analysts at
Raymond James from an “outperform” rating to a “market perform” rating in a
research report issued to clients and investors on Monday, MarketBeat.com
reports. Other equities analysts have also recently issued reports about the
company. Bank of America upgraded HCP from a “neutral” rating to a “buy” rating
and lifted their price target for the company from $22.63 to $25.00 in a
research report on Thursday, March 8th. Mizuho set a $26.00 price target on HCP
and gave the company a “buy” rating in a research report on Thursday, February
15th. Stifel Nicolaus reiterated a “buy” rating and set a $27.00 price target
(down from $29.00) on shares of HCP in a research report on Wednesday, February
14th. Robert W. Baird set a $24.00 price target on HCP and gave the company a
“hold” rating in a research report on Thursday, February 15th. Finally,
Jefferies Group reiterated a “hold” rating and set a $26.00 price target on
shares of HCP in a research report on Tuesday, February 13th. Four research
analysts have rated the stock with a sell rating, ten have assigned a hold
rating and four have assigned a buy rating to the company. HCP has an average
rating of “Hold” and an average target price of $26.93. Read more …
Ventas (NYSE:VTR) was downgraded by research analysts at
Evercore ISI from an “in-line” rating to an “underperform” rating in a research
note issued on Monday, Marketbeat Ratings reports. VTR has been the topic of
several other reports. ValuEngine cut shares of Ventas from a “hold” rating to
a “sell” rating in a research report on Wednesday, May 2nd. Jefferies Group
reissued a “hold” rating and issued a $54.00 price objective on shares of
Ventas in a research report on Tuesday, February 13th. Wells Fargo set a $54.00
price objective on shares of Ventas and gave the stock a “hold” rating in a
research report on Tuesday, February 13th. Hilliard Lyons raised shares of
Ventas from a “neutral” rating to a “buy” rating in a research report on
Friday, April 27th. Finally, SunTrust Banks set a $55.00 price objective on
shares of Ventas and gave the stock a “hold” rating in a research report on
Friday, February 9th. Six research analysts have rated the stock with a sell
rating, eleven have assigned a hold rating and three have given a buy rating to
the stock. The stock presently has a consensus rating of “Hold” and an average
price target of $57.69. Read more …
AbbVie (NYSE:ABBV) was downgraded by stock analysts at
Goldman Sachs Group from a “conviction-buy” rating to a “buy” rating in a note
issued to investors on Thursday, The Fly reports. A number of other research
firms have also weighed in on ABBV. SunTrust Banks raised their price target on
shares of AbbVie to $157.00 and gave the company an “average” rating in a
research report on Monday, January 29th. Piper Jaffray Companies lifted their
price objective on shares of AbbVie from $115.00 to $130.00 and gave the stock
an “outperform” rating in a research report on Friday, January 26th. BMO
Capital Markets lowered shares of AbbVie from a “market perform” rating to an
“underperform” rating and lowered their price objective for the stock from
$125.86 to $84.00 in a research report on Monday, January 29th. They noted that
the move was a valuation call. Leerink Swann lowered shares of AbbVie from an
“outperform” rating to a “market perform” rating and set a $127.00 price
objective on the stock. in a research report on Monday, January 29th. Finally,
Evercore ISI reaffirmed a “buy” rating and issued a $144.00 price objective on
shares of AbbVie in a research report on Monday, January 29th. One research
analyst has rated the stock with a sell rating, nine have given a hold rating,
eight have issued a buy rating and two have given a strong buy rating to the
company. AbbVie currently has an average rating of “Buy” and a consensus price
target of $116.20. Read more …
No comments:
Post a Comment